Cholestasis alters polarization and suppressor function of hepatic regulatory T cells.
Kudira, R.; Yang, Z. F.; Osuji, I.; Karns, R.; Bariya, P.; Pfuhler, L.; Mullen, M.; Taylor, A.; Ji, H.; Lages, C. S.; Yang vom Hofe, A.; Shi, T.; Pasula, S.; Wayman, J. A.; Bernieh, A.; Zhang, W.; Chougnet, C. A.; Hildeman, D.; Tiao, G. M.; Huppert, S. S.; Subramanian, S.; Salomonis, N.; Miraldi, E.; Miethke, A. G.
Show abstract
Fibrosing cholangiopathies, including biliary atresia and primary sclerosing cholangitis, involve immune-mediated bile duct epithelial injury and hepatic bile acid (BA) retention (cholestasis). Regulatory T-cells (Tregs) can prevent auto-reactive lymphocyte activation, yet the effects of BA on this CD4 lymphocyte subset are unknown. Gene regulatory networks for hepatic CD4 lymphocytes in a murine cholestasis model revealed Tregs are polarized to Th17 during cholestasis. Following bile duct ligation, Stat3 deletion in CD4 lymphocytes preserved hepatic Treg responses. While pharmacological reduction of hepatic BA in MDR2-/- mice prompted Treg expansion and diminished liver injury, this improvement subsided with Treg depletion. A cluster of patients diagnosed with biliary atresia showed both increased hepatic Treg responses and improved 2-year native liver survival, supporting that Tregs might protect against neonatal bile duct obstruction. Together, these findings suggest liver BA determine Treg function and should be considered as a therapeutic target to restore protective hepatic immune responses.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.